Hepatic artery infusion pumps recalled
The recall was initiated after reports from clinicians that the pumps were delivering medications faster than expected.
The FDA announced a class I recall of the Intera 3000 Hepatic Artery Infusion Pump by Intera Oncology on Aug. 30.
The company initiated the recall after reports from clinicians that the pumps were delivering medications faster than expected. No associated injuries or deaths have been reported. The recall includes 50 devices distributed from Aug. 12, 2021, to May 17, 2022.